Europe Healthcare Contract Research Organizations (CRO) Services Market is expected to reach US$ 26,094.15 Mn in 2027

Published Date: 13 Aug 2020

Report : Europe Healthcare Contract Research Organizations (CRO) Services Market Forecast to 2027 - COVID-19 Impact and Regional Analysis byService Type (Early Phase Development, Laboratory Services, Consulting Services, Clinical Research Services); Therapeutic Indication (Oncology, Infectious Diseases, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, Others); End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Others (Academic Institutes), and Country

According to our new market research study on “Europe Healthcare Contract Research Organizations (CRO) Services Market to 2027 – Regional Analysis and Forecast – by Service Type, Therapeutic Indication and End-User” the market is expected to reach US$ 26,094.15 million by 2027 from US$ 13,776.13 million in 2019; it is estimated to grow at a CAGR of 8.5% from 2020 to 2027. The report provides trends prevailing in the Europe healthcare contract research organizations (CRO) services market and the factors driving the market growth along with those hindering it.

Based on service type, the healthcare contract research organizations (CRO) services market is further segmented into early phase development, laboratory services, consulting services, and clinical research services. Early phase development market is further categorized into discovery studies, chemistry, marketing & manufacturing, and preclinical market. The laboratory services segment is further sub segmented as bio-analytical testing and analytical testing. The clinical research services segment is further bifurcated into phase I, phase II, phase III, and phase IV. In 2019, the clinical research segment accounted for the largest share of the market. Growth of this segment is attributed to the increasing clinical trials and growing R&D investment.

The growth of the Europe healthcare contract research organizations (CRO) services market is mainly attributed as growing number of clinical trials and increasing expenditure in R&D and outsourcing activities in the country. However, the stringent regulations for approval of drugs is the major factor hindering the market growth in Europe.

A few of the leading companies operating in the Europe healthcare contract research organizations (CRO) services market are ICON plc, IQVIA INC, Laboratory Corporation of America Holdings (Covance), PRA Health Sciences, and Syneos Health.

The report segments Europe Healthcare Contract Research Organizations (CRO) Services Market as follows:

Europe Healthcare Contract Research Organizations (CRO) Services Market – By Service Type

  • Early Phase Development
  • Laboratory Services
  • Consulting Services
  • Clinical Research Services

Europe Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Indication

  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others

Europe Healthcare Contract Research Organizations (CRO) Services Market – By End-User

  • Medical Device Companies
  • Pharmaceutical and Biopharmaceutical Companies
  • Others (Academic Institutes)

Europe Healthcare Contract Research Organizations (CRO) Services Market – By Country

  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Download PDF Brochure